Society of Interventional Radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous …

IJ Patel, S Rahim, JC Davidson, SE Hanks… - Journal of Vascular and …, 2019 - Elsevier
Part II of the consensus guidelines updates the recommendations for the periprocedural
management of thrombotic and bleeding risks in patients who require image-guided …

Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of regional anesthesia and …

S Narouze, HT Benzon, D Provenzano… - Regional Anesthesia & …, 2018 - rapm.bmj.com
Abstract The American Society of Regional Anesthesia and Pain Medicine (ASRA) 2012
survey of meeting attendees showed that existing ASRA anticoagulation guidelines for …

Functional gene variants of CYP3A4

AN Werk, I Cascorbi - Clinical Pharmacology & Therapeutics, 2014 - Wiley Online Library
Cytochrome P450 3A4 (CYP3A4) is involved in the metabolism of more drugs in clinical use
than any other foreign compound–metabolizing enzyme in humans. Recently, increasing …

Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and …

S Narouze, HT Benzon, DA Provenzano… - Regional Anesthesia & …, 2015 - rapm.bmj.com
Interventional spine and pain procedures cover a far broader spectrum than those for
regional anesthesia, reflecting diverse targets and goals. When surveyed, interventional …

CDK4/6 inhibitors in breast cancer treatment: potential interactions with drug, gene, and pathophysiological conditions

R Roncato, J Angelini, A Pani, E Cecchin… - International journal of …, 2020 - mdpi.com
Palbociclib, ribociclib, and abemaciclib belong to the third generation of cyclin-dependent
kinases inhibitors (CDKis), an established therapeutic class for advanced and metastatic …

Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population

GX Hu, DP Dai, H Wang, XX Huang, XY Zhou… - …, 2017 - Taylor & Francis
Aim: To systematically investigate the genetic polymorphisms of the CYP3A4 gene in a Han
Chinese population. Materials & methods: The promoter and exons of CYP3A4 gene in …

The influence of the CYP3A4* 22 polymorphism and CYP2D6 polymorphisms on serum concentrations of aripiprazole, haloperidol, pimozide, and risperidone in …

K van der Weide, J van der Weide - Journal of clinical …, 2015 - journals.lww.com
Methods Eight hundred thirty-four adult patients were included in this study, of whom 130
used aripiprazole, 312 used haloperidol, 86 used pimozide, and 396 used risperidone …

CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel

MT Holmberg, A Tornio… - Clinical …, 2019 - Wiley Online Library
CYP3A enzymes participate in the elimination of ticagrelor and the bioactivation of
clopidogrel and prasugrel. We studied the effects of functional CYP3A genetic variants …

[HTML][HTML] Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome

C Dong, H Zhou, C Shen, LG Yu, Y Ding… - World journal of …, 2015 - ncbi.nlm.nih.gov
Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are the serious public
health problems worldwide. Moreover, it is estimated that MetS patients have about five-fold …

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19

Y Yang, JP Lewis, JS Hulot, SA Scott - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Aspirin, clopidogrel, prasugrel and ticagrelor are antiplatelet agents for the
prevention of ischemic events in patients with acute coronary syndromes (ACS) …